Sunshine Heart Inc (NASDAQ:CHFS) traded up 0.5% during trading on Wednesday . The company traded as high as $3.98 and last traded at $3.83. 183,865 shares traded hands during mid-day trading, a decline of 61% from the average session volume of 467,404 shares. The stock had previously closed at $3.85.
Separately, Zacks Investment Research downgraded Sunshine Heart from a “buy” rating to a “hold” rating in a research report on Thursday, January 11th.
The company has a market capitalization of $6.36, a PE ratio of -0.03 and a beta of 2.31.
Sunshine Heart Company Profile
CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
Receive News & Ratings for Sunshine Heart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunshine Heart and related companies with MarketBeat.com's FREE daily email newsletter.